Independent UK medicine guidance
Mounjaro and periods: irregular cycles, heavier or lighter bleeding and fertility
Changes to periods are not listed as a side effect of Mounjaro (tirzepatide), but they are one of the most common things people notice after starting. The likely reason is not the medicine acting on the womb; it is that significant weight loss changes the hormones that run the cycle, especially in people with polycystic ovary syndrome. That can mean cycles returning, cycles going haywire for a while, and, importantly, fertility returning when it was assumed to be low. This guide covers what to expect and what needs a GP.
Key facts
- Menstrual changes are not listed in the UK Mounjaro leaflet.[1]
- Weight loss itself changes cycles. The NHS notes that losing weight can restore ovulation and regular periods in women with PCOS.[2]
- Fertility can return. Tirzepatide should not be used during pregnancy and is not recommended in women of childbearing potential who are not using contraception; stop at least one month before a planned pregnancy.[3]
- If you use the combined pill or other oral contraception, Mounjaro can reduce how well it works after starting and after each dose increase; the leaflet and SmPC set out what to do.[1],[3] See our contraception guide.
- Red flag: very heavy bleeding, bleeding after the menopause, or severe pelvic pain needs a GP or 111 whatever medicine you are on.
What people notice
- Periods returning after years of absence, particularly with PCOS
- Cycles that were regular becoming irregular for a few months
- Lighter or heavier bleeding than before
- Worse or better PMS
- Spotting between periods, especially in people using hormonal contraception
- An unexpected pregnancy
Why weight loss changes the cycle
Fat tissue makes oestrogen and drives insulin resistance, and both influence the signals between the brain and the ovaries. In PCOS, excess weight and insulin resistance are part of what stops ovulation; the NHS advises that even modest weight loss can bring periods and ovulation back.[2] When weight falls quickly, the system recalibrates, and the first few cycles after a change are often irregular before they settle.
Tirzepatide also improves insulin sensitivity directly, which is part of how it treats type 2 diabetes.[3] That may add to the effect in PCOS, though it has not been studied as a PCOS treatment in the UK licence and Mounjaro is not licensed for it.
Rapid weight loss and very low intake can also do the opposite and stop periods. If yours have stopped and you are not pregnant, that is worth a GP visit and a look at whether you are eating enough.
The fertility point, plainly
If you have not been using contraception because you believed you could not conceive, that belief may no longer hold once weight comes off. Tirzepatide should not be used during pregnancy, and is not recommended in women of childbearing potential who are not using contraception. If you want to become pregnant, the SmPC says treatment should be stopped at least one month beforehand, because the medicine stays in the body a long time.[3] Breastfeeding is a separate question and the position has changed: the current SmPC says tirzepatide could be considered for use during breastfeeding, so ask your prescriber rather than assuming either way.[3] Our pregnancy guide has the detail.
Contraception on Mounjaro
Tirzepatide slows stomach emptying, which can reduce the absorption of oral medicines. In a study, a single dose cut the peak levels of the hormones in a combined pill by more than half. The SmPC says that single-dose reduction is not clinically relevant in women with a normal BMI, but that information is limited in women who are overweight or have obesity, so reduced efficacy cannot be excluded: it advises switching to a non-oral method, or adding a barrier method for four weeks after starting and for four weeks after each dose increase.[3] Since weight management is exactly that population, treat the four-week advice as applying to you. Implants, injections, patches, rings and coils are unaffected. The contraception guide sets this out in full; if in doubt, ask your prescriber or a sexual health clinic.
When to see your GP
See your GP if periods have stopped for three months or more and you are not pregnant, if bleeding is much heavier than usual or lasts more than seven days, if you bleed between periods or after sex, if you have any bleeding after the menopause, or if pelvic pain is severe.[4] These are standard NHS reasons to be seen and have nothing to do with the medicine, but the medicine does not make them less important.
Tell your GP you are taking Mounjaro and how much weight you have lost; it changes how they interpret the picture. Our guide explains whether your pharmacy has told them already.
Common questions
Does Mounjaro affect your period?
Not directly, as far as the product information records. Weight loss affects the hormones that control the cycle, so irregular, returning, lighter or heavier periods are common in the months after starting, especially with PCOS.
Can Mounjaro make you more fertile?
Weight loss can restore ovulation in people whose periods had stopped, which means fertility can return. Tirzepatide should not be used during pregnancy, so reliable contraception matters throughout treatment, and it should be stopped at least a month before trying to conceive.
Does Mounjaro affect the pill?
It can reduce absorption of oral contraceptives after starting and after each dose increase. The product information advises a non-oral method or adding a barrier method for four weeks at those points. Non-oral methods are not affected.
My periods have stopped on Mounjaro. Is that normal?
Rule out pregnancy first. Rapid weight loss and eating too little can stop periods, and so can other conditions. Three months without a period, not explained by pregnancy or contraception, is a reason to see your GP.
Related guides
About this page. Monj is an independent information and price comparison service run by Medstack Ltd. It is not a pharmacy and does not prescribe, dispense or sell medicines. This page provides general information, not diagnosis or individual medical advice, and it does not diagnose PCOS or any other condition. It has not been clinically reviewed; a named clinical reviewer will be added when one has approved it. Read our editorial and review policy and independence statement.
References
- Eli Lilly. Mounjaro KwikPen: Package leaflet, information for the patient (UK), revised August 2026. electronic medicines compendium. medicines.org.uk/emc/product/15481/pil. Accessed 6 September 2026.
- NHS. Polycystic ovary syndrome: treatment. nhs.uk/conditions/polycystic-ovary-syndrome-pcos/treatment. Accessed 6 September 2026.
- Eli Lilly. Mounjaro KwikPen: Summary of Product Characteristics (UK), sections 4.5, 4.6 and 5.1. electronic medicines compendium. medicines.org.uk/emc/product/15481/smpc. Accessed 6 September 2026.
- NHS. Periods. nhs.uk/conditions/periods. Accessed 6 September 2026.
Explore other side effects
Tap a point on the body to jump to that symptom, or choose from the full list below. The pink marker shows where you are now.
© 2026 Medstack Ltd. Written and published by Monj (monj.co.uk). You are welcome to link to this page or quote a short extract with a credit and a link. Republishing the text, page structure, safety-routing design or price data, in whole or in part, including to train or ground an automated system, is not permitted without written permission. See our independence statement and editorial and review policy.
